JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB157249

Anti-HIF-2-alpha antibody [OTI2G5]

3

(1 Review)

|

(7 Publications)

Mouse Monoclonal HIF-2-alpha antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Recombinant Fragment Protein within Human EPAS1 aa 550 to C-terminus.

View Alternative Names

BHLHE73, HIF2A, MOP2, PASD2, EPAS1, Endothelial PAS domain-containing protein 1, EPAS-1, Basic-helix-loop-helix-PAS protein MOP2, Class E basic helix-loop-helix protein 73, HIF-1-alpha-like factor, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, PAS domain-containing protein 2, bHLHe73, HLF, HIF-2-alpha, HIF2-alpha

2 Images
Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (AB157249)
  • WB

Supplier Data

Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (AB157249)

False colour image of Western blot : Anti-HIF-2-alpha antibody [OTI2G5] staining at 1/500 dilution, shown in black; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab157249 was shown to bind specifically to HIF-2-alpha. A band was observed at 100 kDa in treated wild-type A549 cell lysates with no signal observed at this size in EPAS1 knockout cell line ab259774 (knockout cell lysate ab259779). To generate this image, wild-type and EPAS1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % BSA in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 20 seconds exposure time. Secondary antibodies used were HRP conjugated Goat anti-Mouse (H+L) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (ab157249) at 1/500 dilution

Lane 1:

Wild-type A549 Untreated (DFO Control) cell lysate at 20 µg

Lane 2:

Wild-type A549 Treated DFO (1 mM, 24 h) cell lysate at 20 µg

Lane 2:

Western blot - Human EPAS1 (HIF-2-alpha) knockout A549 cell line (<a href='/en-us/products/cell-lines/human-epas1-hif-2-alpha-knockout-a549-cell-line-ab259774'>ab259774</a>)

Lane 3:

EPAS1 knockout A549 Untreated (DFO Control) cell lysate at 20 µg

Lane 4:

EPAS1 knockout A549 Treated DFO (1 mM, 24 h) cell lysate at 20 µg

Predicted band size: 96 kDa

Observed band size: 100 kDa

false

Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (AB157249)
  • WB

Unknown

Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (AB157249)

HEK293T cell lysates were generated from transient transfection of the cDNA clone (RC216194)

All lanes:

Western blot - Anti-HIF-2-alpha antibody [OTI2G5] (ab157249) at 1/2000 dilution

Lane 1:

HEK293T cells transfected with pCMV6-ENTRY control at 5 µg

Lane 2:

HEK293T cells transfected with pCMV6-ENTRY HIF2 alpha at 5 µg

Predicted band size: 96 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

OTI2G5

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Recombinant Fragment Protein within Human EPAS1 aa 550 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q99814

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>" } } }

Product details

The clone number has been updated from 2G5 to OTI2G5, both clone numbers name the same clone.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
Purified from TCS
Storage buffer
pH: 7.3 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HIF-2-alpha also known as hypoxia-inducible factor 2-alpha or EPAS1 plays a significant role in cellular response to oxygen levels. Mechanically HIF-2-alpha functions as a transcription factor that activates certain genes when oxygen is low. The protein typically weighs around 118 kDa. It is expressed in various tissues but particularly in endothelial cells and some neuronal tissues. These sites highlight its importance in organs requiring tight regulation of oxygen.
Biological function summary

HIF-2-alpha regulates the expression of genes involved in energy metabolism and angiogenesis. The protein forms a complex by dimerizing with the HIF-1-beta subunit which is necessary for transcriptional activity. Through this complex formation and activity it influences processes such as erythropoiesis and regulates factors like vascular endothelial growth factor (VEGF). Therefore HIF-2-alpha contributes to the adaptation of cells and tissues under hypoxic conditions.

Pathways

HIF-2-alpha engages in the hypoxia signaling pathway playing an essential part by modulating gene expression in response to low oxygen availability. This role impacts other proteins such as HIF-1-alpha sharing overlapping functions but with distinct target genes. Additionally HIF-2-alpha is involved in the mTOR pathway which influences cell growth and metabolism through its interaction with the nutrient-sensing regulatory pathway.

Researchers have linked HIF-2-alpha with conditions like renal cell carcinoma and pulmonary hypertension. The protein's dysregulation can lead to altered expression of angiogenic factors promoting tumor growth and survival. In particular its connection with VEGF exemplifies its role in these pathologies by facilitating aberrant blood vessel formation. Such interactions further highlight the potential of HIF-2-alpha as a therapeutic target in disease modulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor involved in the induction of oxygen regulated genes. Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation requires recruitment of transcriptional coactivators such as CREBBP and probably EP300. Interaction with redox regulatory protein APEX1 seems to activate CTAD (By similarity).
See full target information EPAS1

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Proceedings of the National Academy of Sciences of the United States of America 119:e2119854119 PubMed36037364

2022

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Haibiao Xie,Jin Zhou,Xijuan Liu,Yawei Xu,Austin J Hepperla,Jeremy M Simon,Tao Wang,Hongwei Yao,Chengheng Liao,Albert S Baldwin,Kan Gong,Qing Zhang

Proceedings of the National Academy of Sciences of 117:13023-13032 PubMed32461361

2020

USP37 promotes deubiquitination of HIF2α in kidney cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Kai Hong,Lianxin Hu,Xijuan Liu,Jeremy M Simon,Travis S Ptacek,Xingnan Zheng,Chengheng Liao,Albert S Baldwin,Qing Zhang

Cancer discovery 10:460-475 PubMed31810986

2019

TBK1 Is a Synthetic Lethal Target in Cancer with Loss.

Applications

Unspecified application

Species

Unspecified reactive species

Lianxin Hu,Haibiao Xie,Xijuan Liu,Frances Potjewyd,Lindsey I James,Emily M Wilkerson,Laura E Herring,Ling Xie,Xian Chen,Johnny Castillo Cabrera,Kai Hong,Chengheng Liao,Xianming Tan,Albert S Baldwin,Kan Gong,Qing Zhang

Oncology research 26:1055-1062 PubMed29321085

2018

MicroRNA-519d-3p Inhibits Proliferation and Promotes Apoptosis by Targeting HIF-2α in Cervical Cancer Under Hypoxic Conditions.

Applications

Unspecified application

Species

Unspecified reactive species

Lixia Jiang,Shaohua Shi,Qiaofa Shi,Huijuan Zhang,Yu Xia,Tianyu Zhong

Oncology letters 14:5643-5651 PubMed29098039

2017

Similarity in the functions of HIF-1α and HIF-2α proteins in cervical cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Lixia Jiang,Shaohua Shi,Qiaofa Shi,Huijuan Zhang,Rong Hu,Meizhen Wang

The EMBO journal 33:1365-82 PubMed24837709

2014

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.

Applications

ICC/IF, WB

Species

Unspecified reactive species, Unspecified reactive species

Vincent Zecchini,Basetti Madhu,Roslin Russell,Nelma Pértega-Gomes,Anne Warren,Edoardo Gaude,Joana Borlido,Rory Stark,Heather Ireland-Zecchini,Roheet Rao,Helen Scott,Joan Boren,Charlie Massie,Mohammad Asim,Kevin Brindle,John Griffiths,Christian Frezza,David E Neal,Ian G Mills

Journal of neurochemistry 129:400-12 PubMed24266789

2013

Fatty acid biosynthesis from glutamate and glutamine is specifically induced in neuronal cells under hypoxia.

Applications

Unspecified application

Species

Unspecified reactive species

Stephen A Brose,Amanda L Marquardt,Mikhail Y Golovko
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com